Use of inhibin B in recurrent ovarian granulosa cell tumors

Early diagnosis of recurrent ovarian granulose cell tumors (OGCT) remains an urgent problem of modern oncogynecology. Inhibin B is one of the most potentially important markers of OGCT. Nevertheless, in the world there are today only single studies evaluating the clinical value of inhibin B. The pap...

Full description

Saved in:
Bibliographic Details
Main Authors: A. M. Beishembayev, N. V. Lyubimova, V. M. Abayev, K. I. Zhordania, V. A. Khailenko
Format: Article
Language:Russian
Published: ABV-press 2014-08-01
Series:Опухоли женской репродуктивной системы
Subjects:
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/253
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849403705184485376
author A. M. Beishembayev
N. V. Lyubimova
V. M. Abayev
K. I. Zhordania
V. A. Khailenko
author_facet A. M. Beishembayev
N. V. Lyubimova
V. M. Abayev
K. I. Zhordania
V. A. Khailenko
author_sort A. M. Beishembayev
collection DOAJ
description Early diagnosis of recurrent ovarian granulose cell tumors (OGCT) remains an urgent problem of modern oncogynecology. Inhibin B is one of the most potentially important markers of OGCT. Nevertheless, in the world there are today only single studies evaluating the clinical value of inhibin B. The paper presents serum inhibin B measurements in patients with recurrent OGCT. The findings suggest that inhibin B has a high (80-100%) diagnostic sensitivity and 100% specificity.
format Article
id doaj-art-bbca4f874f18422da8fcee226c177201
institution Kabale University
issn 1994-4098
1999-8627
language Russian
publishDate 2014-08-01
publisher ABV-press
record_format Article
series Опухоли женской репродуктивной системы
spelling doaj-art-bbca4f874f18422da8fcee226c1772012025-08-20T03:37:11ZrusABV-pressОпухоли женской репродуктивной системы1994-40981999-86272014-08-0103687210.17650/1994-4098-2010-0-3-68-72269Use of inhibin B in recurrent ovarian granulosa cell tumorsA. M. Beishembayev0N. V. Lyubimova1V. M. Abayev2K. I. Zhordania3V. A. Khailenko4Department of Oncology, Russian State Medical University, Russian Agency for Health CareN.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical Sciences, MoscowN.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical Sciences, MoscowN.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical Sciences, MoscowDepartment of Oncology, Russian State Medical University, Russian Agency for Health CareEarly diagnosis of recurrent ovarian granulose cell tumors (OGCT) remains an urgent problem of modern oncogynecology. Inhibin B is one of the most potentially important markers of OGCT. Nevertheless, in the world there are today only single studies evaluating the clinical value of inhibin B. The paper presents serum inhibin B measurements in patients with recurrent OGCT. The findings suggest that inhibin B has a high (80-100%) diagnostic sensitivity and 100% specificity.https://ojrs.abvpress.ru/ojrs/article/view/253inhibin bovarian granulose cell tumorsrecurrences
spellingShingle A. M. Beishembayev
N. V. Lyubimova
V. M. Abayev
K. I. Zhordania
V. A. Khailenko
Use of inhibin B in recurrent ovarian granulosa cell tumors
Опухоли женской репродуктивной системы
inhibin b
ovarian granulose cell tumors
recurrences
title Use of inhibin B in recurrent ovarian granulosa cell tumors
title_full Use of inhibin B in recurrent ovarian granulosa cell tumors
title_fullStr Use of inhibin B in recurrent ovarian granulosa cell tumors
title_full_unstemmed Use of inhibin B in recurrent ovarian granulosa cell tumors
title_short Use of inhibin B in recurrent ovarian granulosa cell tumors
title_sort use of inhibin b in recurrent ovarian granulosa cell tumors
topic inhibin b
ovarian granulose cell tumors
recurrences
url https://ojrs.abvpress.ru/ojrs/article/view/253
work_keys_str_mv AT ambeishembayev useofinhibinbinrecurrentovariangranulosacelltumors
AT nvlyubimova useofinhibinbinrecurrentovariangranulosacelltumors
AT vmabayev useofinhibinbinrecurrentovariangranulosacelltumors
AT kizhordania useofinhibinbinrecurrentovariangranulosacelltumors
AT vakhailenko useofinhibinbinrecurrentovariangranulosacelltumors